Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Steven Joseph Haas"'
Publikováno v:
The Lancet. 369:381-388
Summary Background Recombinant human erythropoietin is commonly used for treatment of anaemia. Our aim was to determine whether targeting different haemoglobin concentrations with such treatment is associated with altered all-cause mortality and card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72699e8348d89b4e056a0f0f4f11dc61
https://doi.org/10.1016/s0140-6736(07)60194-9
https://doi.org/10.1016/s0140-6736(07)60194-9
Autor:
Hans Wedel, Ellen B. Roecker, Henry Krum, Patricia Verkenne, Jalal K. Ghali, Edward M. Gilbert, Eric J. Eichhorn, Philippe Lechat, John Wikstrand, Milton Packer, Steven Joseph Haas
Publikováno v:
European Heart Journal. 26:2154-2158
Aims Beta-blockers (BBs) confer significant prognostic benefit in patients (pts) with systolic chronic heart failure (CHF). However, major trials have thus far studied BBs mainly in addition to ACE-Inhibitors or angiotensin receptor blockers (ARBs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4c71a271f615bf00bd0195ce354ddd
https://doi.org/10.1093/eurheartj/ehi409
https://doi.org/10.1093/eurheartj/ehi409
Publikováno v:
The American Journal of Cardiology. 95:896-898
A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart failure patients from 5 completed beta-blocker trials revealed that elderly and non-elderly chronic heart failure patients derived considerable prognostic ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a7a367b8be47d153130c039b31f716
https://doi.org/10.1016/j.amjcard.2004.11.052
https://doi.org/10.1016/j.amjcard.2004.11.052
Autor:
Pramote Porapakkham, Yusuke Sata, Andrew Forbes, Pornwalee Porapakkham, Silviu Itescu, Hendrik Zimmet, Henry Krum, Steven Joseph Haas
Publikováno v:
European journal of heart failure. 14(1)
Aims Bone marrow stem cell (BMSC) treatment of ST-segment elevation myocardial infarction (STEMI) has been primarily via the intracoronary route or via endogenous mobilization using granulocyte colony-stimulating factor (G-CSF). Studies have provided
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538c8af105a755a6b034b600a2ef2a35
https://pubmed.ncbi.nlm.nih.gov/22147203
https://pubmed.ncbi.nlm.nih.gov/22147203
Publikováno v:
Archives of internal medicine. 167(14)
There is uncertainty regarding which pharmacological agents most effectively prevent venous thromboembolism in hospitalized medical patients. We therefore performed a meta-analysis to determine this.MEDLINE, EMBASE, and the Cochrane Central Register
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d94e79bf065ff797702aeda47bab52
https://pubmed.ncbi.nlm.nih.gov/17912782
https://pubmed.ncbi.nlm.nih.gov/17912782
Autor:
Gerald F. Watts, K Ng, Henry Krum, Steven Joseph Haas, Afif Hadj, Jee Yoong Leong, Franklin L. Rosenfeldt
Publikováno v:
Journal of human hypertension. 21(4)
Our objective was to review all published trials of coenzyme Q10 for hypertension, assess overall efficacy and consistency of therapeutic action and side effect incidence. Meta-analysis was performed in 12 clinical trials (362 patients) comprising th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954bc411c4da81a1f76d0cc6fe642f8e
https://pubmed.ncbi.nlm.nih.gov/17287847
https://pubmed.ncbi.nlm.nih.gov/17287847
Autor:
Steven Joseph Haas, Silvana Marasco, Henry Krum, Franklin L. Rosenfeldt, Salvatore Pepe, Freya L. Sheeran
Publikováno v:
Mitochondrion.
In this review we summarise the current state of knowledge of the therapeutic efficacy and mechanisms of action of CoQ(10) in cardiovascular disease. Our conclusions are: 1. There is promising evidence of a beneficial effect of CoQ(10) when given alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952488058c293bd198f2519efcaf1aed
https://pubmed.ncbi.nlm.nih.gov/17485243
https://pubmed.ncbi.nlm.nih.gov/17485243
Publikováno v:
Journal of cardiovascular pharmacology. 47
There has been significant recent interest in the cardiovascular effects of cyclooxygenase 2 (COX-2) selective inhibitors. Whereas much attention has been focused on the putative prothrombotic effect of these agents, their cardiorenal and blood press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d7cf6e1cd925218eb5a2c726e0ef54d
https://pubmed.ncbi.nlm.nih.gov/16785828
https://pubmed.ncbi.nlm.nih.gov/16785828
Autor:
Steven Joseph Haas
Publikováno v:
Southern medical journal. 99(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a7c9af90806844cf79553a9cc7e731
https://pubmed.ncbi.nlm.nih.gov/16634247
https://pubmed.ncbi.nlm.nih.gov/16634247
Publikováno v:
Monash University
Background: Nonselective nonsteroidal antiinflammatorydrugs(NSAIDs)arewidelyprescribedand are associated with blood pressure (BP) elevation. The development of selective cyclooxygenase-2 inhibitors (coxibs) raises the issue of the magnitude of BP res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82943cea07ce696d963f85bd2d795e6
https://pubmed.ncbi.nlm.nih.gov/15710786
https://pubmed.ncbi.nlm.nih.gov/15710786